BR112014031407B1 - Método e dispositivo para o monitoramento de um tratamento de sangue extracorpóreo de um paciente e aparelho de tratamento de sangue extracorpóreo para execução de um tratamento de sangue extracorpóreo em um paciente - Google Patents
Método e dispositivo para o monitoramento de um tratamento de sangue extracorpóreo de um paciente e aparelho de tratamento de sangue extracorpóreo para execução de um tratamento de sangue extracorpóreo em um paciente Download PDFInfo
- Publication number
- BR112014031407B1 BR112014031407B1 BR112014031407-1A BR112014031407A BR112014031407B1 BR 112014031407 B1 BR112014031407 B1 BR 112014031407B1 BR 112014031407 A BR112014031407 A BR 112014031407A BR 112014031407 B1 BR112014031407 B1 BR 112014031407B1
- Authority
- BR
- Brazil
- Prior art keywords
- intensity
- polarization
- anisotropy
- fluid sample
- fluorescence light
- Prior art date
Links
- 238000011282 treatment Methods 0.000 title claims abstract description 53
- 238000000034 method Methods 0.000 title claims abstract description 50
- 210000004369 blood Anatomy 0.000 title claims abstract description 37
- 239000008280 blood Substances 0.000 title claims abstract description 37
- 238000012544 monitoring process Methods 0.000 title claims abstract description 15
- 230000010287 polarization Effects 0.000 claims abstract description 69
- 239000000385 dialysis solution Substances 0.000 claims abstract description 42
- 238000000502 dialysis Methods 0.000 claims abstract description 41
- 238000001514 detection method Methods 0.000 claims abstract description 14
- 238000001631 haemodialysis Methods 0.000 claims abstract description 13
- 230000000322 hemodialysis Effects 0.000 claims abstract description 13
- 239000012530 fluid Substances 0.000 claims description 56
- 238000001228 spectrum Methods 0.000 claims description 23
- 239000000126 substance Substances 0.000 claims description 23
- 230000007704 transition Effects 0.000 claims description 21
- 108091006905 Human Serum Albumin Proteins 0.000 claims description 20
- 102000008100 Human Serum Albumin Human genes 0.000 claims description 20
- 230000005855 radiation Effects 0.000 claims description 16
- 230000001678 irradiating effect Effects 0.000 claims description 11
- 238000002615 hemofiltration Methods 0.000 claims description 9
- 238000005259 measurement Methods 0.000 claims description 9
- 230000005540 biological transmission Effects 0.000 claims description 6
- 230000028161 membrane depolarization Effects 0.000 claims description 5
- 230000035945 sensitivity Effects 0.000 claims description 5
- 238000004458 analytical method Methods 0.000 claims description 4
- 230000000694 effects Effects 0.000 claims description 4
- 230000005684 electric field Effects 0.000 claims description 4
- 238000000354 decomposition reaction Methods 0.000 claims description 2
- 239000011159 matrix material Substances 0.000 claims description 2
- 230000005284 excitation Effects 0.000 description 28
- 239000012528 membrane Substances 0.000 description 23
- 210000004379 membrane Anatomy 0.000 description 21
- 102000009027 Albumins Human genes 0.000 description 14
- 108010088751 Albumins Proteins 0.000 description 14
- 102000004169 proteins and genes Human genes 0.000 description 13
- 108090000623 proteins and genes Proteins 0.000 description 13
- 230000006870 function Effects 0.000 description 11
- 238000010521 absorption reaction Methods 0.000 description 10
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 8
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 8
- 238000010586 diagram Methods 0.000 description 8
- BXFFHSIDQOFMLE-UHFFFAOYSA-N indoxyl sulfate Chemical compound C1=CC=C2C(OS(=O)(=O)O)=CNC2=C1 BXFFHSIDQOFMLE-UHFFFAOYSA-N 0.000 description 8
- 230000008569 process Effects 0.000 description 8
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 6
- 239000004202 carbamide Substances 0.000 description 6
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 6
- 230000005281 excited state Effects 0.000 description 6
- 230000005283 ground state Effects 0.000 description 5
- 239000011148 porous material Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 239000000306 component Substances 0.000 description 4
- 239000003792 electrolyte Substances 0.000 description 4
- 230000003287 optical effect Effects 0.000 description 4
- WGNAKZGUSRVWRH-UHFFFAOYSA-N p-cresol sulfate Chemical compound CC1=CC=C(OS(O)(=O)=O)C=C1 WGNAKZGUSRVWRH-UHFFFAOYSA-N 0.000 description 4
- 238000001069 Raman spectroscopy Methods 0.000 description 3
- 229940109239 creatinine Drugs 0.000 description 3
- 238000009792 diffusion process Methods 0.000 description 3
- 238000002189 fluorescence spectrum Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 210000004303 peritoneum Anatomy 0.000 description 3
- 210000002381 plasma Anatomy 0.000 description 3
- 239000002699 waste material Substances 0.000 description 3
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 2
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 238000000295 emission spectrum Methods 0.000 description 2
- 238000001506 fluorescence spectroscopy Methods 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- IWDCLRJOBJJRNH-UHFFFAOYSA-N p-cresol Chemical compound CC1=CC=C(O)C=C1 IWDCLRJOBJJRNH-UHFFFAOYSA-N 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000002441 uremic toxin Substances 0.000 description 2
- 229940116269 uric acid Drugs 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical compound [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 102000007562 Serum Albumin Human genes 0.000 description 1
- 108010071390 Serum Albumin Proteins 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 238000010306 acid treatment Methods 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 206010002022 amyloidosis Diseases 0.000 description 1
- 239000012491 analyte Substances 0.000 description 1
- 102000015736 beta 2-Microglobulin Human genes 0.000 description 1
- 108010081355 beta 2-Microglobulin Proteins 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000012503 blood component Substances 0.000 description 1
- 210000000476 body water Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 229910052805 deuterium Inorganic materials 0.000 description 1
- 230000005670 electromagnetic radiation Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- QYSGYZVSCZSLHT-UHFFFAOYSA-N octafluoropropane Chemical compound FC(F)(F)C(F)(F)C(F)(F)F QYSGYZVSCZSLHT-UHFFFAOYSA-N 0.000 description 1
- 238000010827 pathological analysis Methods 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 239000012088 reference solution Substances 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 238000012959 renal replacement therapy Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
- A61B5/14558—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using optical sensors, e.g. spectral photometrical oximeters by polarisation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4848—Monitoring or testing the effects of treatment, e.g. of medication
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6846—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
- A61B5/6847—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
- A61B5/6866—Extracorporeal blood circuits, e.g. dialysis circuits
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0071—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence by measuring fluorescence emission
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/14546—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring analytes not otherwise provided for, e.g. ions, cytochromes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7225—Details of analogue processing, e.g. isolation amplifier, gain or sensitivity adjustment, filtering, baseline or drift compensation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
- A61M1/1601—Control or regulation
- A61M1/1603—Regulation parameters
- A61M1/1605—Physical characteristics of the dialysate fluid
- A61M1/1609—Physical characteristics of the dialysate fluid after use, i.e. downstream of dialyser
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
- A61M1/1601—Control or regulation
- A61M1/1619—Sampled collection of used dialysate, i.e. obviating the need for recovery of whole dialysate quantity for post-dialysis analysis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/28—Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
- A61M1/3403—Regulation parameters
- A61M1/3406—Physical characteristics of the filtrate, e.g. urea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
- A61M2205/3306—Optical measuring means
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Medical Informatics (AREA)
- Surgery (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Anesthesiology (AREA)
- Vascular Medicine (AREA)
- Optics & Photonics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Signal Processing (AREA)
- Power Engineering (AREA)
- Artificial Intelligence (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Physiology (AREA)
- Psychiatry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- External Artificial Organs (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261660016P | 2012-06-15 | 2012-06-15 | |
| US61/660,016 | 2012-06-15 | ||
| EP12172251.6A EP2674103A1 (en) | 2012-06-15 | 2012-06-15 | Method and device for monitoring an extracorporeal blood treatment of a patient |
| EP12172251.6 | 2012-06-15 | ||
| PCT/EP2013/062366 WO2013186357A1 (en) | 2012-06-15 | 2013-06-14 | Method and device for monitoring an extracorporeal blood treatment of a patient |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BR112014031407A2 BR112014031407A2 (pt) | 2017-06-27 |
| BR112014031407B1 true BR112014031407B1 (pt) | 2021-12-28 |
Family
ID=46465026
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112014031407-1A BR112014031407B1 (pt) | 2012-06-15 | 2013-06-14 | Método e dispositivo para o monitoramento de um tratamento de sangue extracorpóreo de um paciente e aparelho de tratamento de sangue extracorpóreo para execução de um tratamento de sangue extracorpóreo em um paciente |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US10010289B2 (enExample) |
| EP (2) | EP2674103A1 (enExample) |
| JP (1) | JP6242883B2 (enExample) |
| KR (1) | KR102058260B1 (enExample) |
| CN (1) | CN104363820B (enExample) |
| AU (1) | AU2013276453B2 (enExample) |
| BR (1) | BR112014031407B1 (enExample) |
| CA (1) | CA2876542C (enExample) |
| EA (1) | EA028556B1 (enExample) |
| IN (1) | IN2015DN00165A (enExample) |
| WO (1) | WO2013186357A1 (enExample) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012129501A2 (en) | 2011-03-23 | 2012-09-27 | Nxstage Medical, Inc. | Peritoneal dialysis systems, devices, and methods |
| US9861733B2 (en) | 2012-03-23 | 2018-01-09 | Nxstage Medical Inc. | Peritoneal dialysis systems, devices, and methods |
| JP6303555B2 (ja) * | 2014-02-04 | 2018-04-04 | 株式会社ジェイ・エム・エス | アルブミン濃度測定装置及びアルブミン濃度測定方法 |
| EP3539586B1 (en) | 2014-10-10 | 2022-08-24 | NxStage Medical Inc. | Flow balancing methods |
| JP6595204B2 (ja) * | 2015-04-24 | 2019-10-23 | 株式会社島津製作所 | 光学分析装置 |
| WO2017165887A1 (en) * | 2016-03-25 | 2017-09-28 | The General Hospital Corporation | Polarization-based fluorescent nucleic acid detection |
| EP4052737A1 (en) | 2016-07-18 | 2022-09-07 | NxStage Medical Inc. | Flow balancing devices, methods, and systems |
| US11865243B2 (en) | 2016-08-30 | 2024-01-09 | Nxstage Medical, Inc. | Parameter monitoring in medical treatment systems |
| US11826545B2 (en) | 2016-09-08 | 2023-11-28 | Fresenius Medical Care Holdings, Inc. | Optical blood detection system |
| EP3641850B1 (en) | 2017-06-24 | 2024-10-09 | NxStage Medical Inc. | Peritoneal dialysis fluid preparation systems |
| DE102017114735B4 (de) * | 2017-06-30 | 2019-07-04 | Fresenius Medical Care Deutschland Gmbh | Vorrichtung und Verfahren zur Desinfektion |
| EP3692347B1 (en) * | 2017-10-06 | 2024-03-27 | Bio-Rad Laboratories, Inc. | Protein quantitation devices and method |
| JP6997582B2 (ja) * | 2017-10-17 | 2022-01-17 | 日機装株式会社 | 血液浄化装置 |
| JP2021516089A (ja) | 2018-02-28 | 2021-07-01 | ネクステージ メディカル インコーポレイテッド | 流体調製および処置装置、方法、およびシステム |
| WO2020056808A1 (zh) * | 2018-09-21 | 2020-03-26 | 北京大学深圳医院 | 血液中吲哚氰绿的检测装置及系统 |
| CA3138773A1 (en) | 2019-05-23 | 2020-11-26 | Nxstage Medical, Inc. | Flow synchronization devices, methods and systems |
| CN113994193B (zh) * | 2019-06-26 | 2025-04-04 | 旭化成医疗株式会社 | 浓度计算装置和血液处理系统 |
| CN110691153B (zh) * | 2019-08-27 | 2020-09-22 | 珠海格力电器股份有限公司 | 一种显示模组及终端 |
| US12228564B2 (en) | 2020-01-10 | 2025-02-18 | Fresenius Medical Care Holdings, Inc. | Systems and methods for analyzing spent dialysate |
| JP7680430B2 (ja) * | 2020-03-31 | 2025-05-20 | 旭化成メディカル株式会社 | 血液浄化システム、制御方法、制御プログラム、学習装置及び学習方法 |
| US12036344B2 (en) * | 2020-11-13 | 2024-07-16 | Fresenius Medical Care Holdings, Inc. | Systems and methods for analyzing spent dialysate |
| DE102021113519A1 (de) * | 2021-05-26 | 2022-12-01 | B.Braun Avitum Ag | Optischer Sensor zur Bestimmung einer Dialysedosis |
| JP7754735B2 (ja) * | 2022-02-01 | 2025-10-15 | 日機装株式会社 | 透析排液用成分測定装置及び方法 |
| US20240325615A1 (en) | 2023-03-31 | 2024-10-03 | Baxter International Inc. | System featuring optical and electrical sensors for characterizing effluent from a peritoneal dialysis patient |
| CN116327188B (zh) * | 2023-05-29 | 2023-09-08 | 深圳市亿米生命科技有限公司 | 一种基于指夹式血氧仪的血氧分析方法 |
| CN117250178B (zh) * | 2023-09-19 | 2024-09-13 | 北京艾锐精仪科技有限公司 | 一种荧光各向异性探测方法及其探测系统 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4496722A (en) * | 1981-05-01 | 1985-01-29 | The Children's Medical Center Corporation | Reporter compounds |
| US5515864A (en) * | 1994-04-21 | 1996-05-14 | Zuckerman; Ralph | Method and apparatus for the in vivo measurement of oxygen concentration levels by the indirect determination of fluoescence lifetime |
| EP1080361A4 (en) * | 1998-05-19 | 2005-08-10 | Spectrx Inc | APPARATUS AND METHOD FOR DETERMINING THE CHARACTERISTICS OF FABRICS |
| JP2002098638A (ja) * | 2000-09-26 | 2002-04-05 | Shimadzu Corp | 蛍光偏光度測定装置 |
| EP1469896B1 (en) * | 2002-01-28 | 2010-09-01 | Debiotech S.A. | Peritoneal dialysis system |
| US7326576B2 (en) | 2003-04-09 | 2008-02-05 | Prescient Medical, Inc. | Raman spectroscopic monitoring of hemodialysis |
| DE102005001051B4 (de) | 2005-01-07 | 2007-10-31 | Fresenius Medical Care Deutschland Gmbh | Vorrichtung und Verfahren zur Erkennung von Komplikationen während einer extrakorporalen Blutbehandlung |
| DE102006029899B4 (de) | 2006-06-29 | 2009-06-04 | Fresenius Medical Care Deutschland Gmbh | Spektroskopischer Detektor und Verfahren zur Bestimmung von Blut und biologischen Markersubstanzen in Flüssigkeiten |
| US20080225265A1 (en) * | 2007-03-17 | 2008-09-18 | Mi Research, Inc. | Method and apparatus for finding macromolecule crystallization conditions |
| US20110188043A1 (en) * | 2007-12-26 | 2011-08-04 | Yissum, Research Development Company of The Hebrew University of Jerusalem, Ltd. | Method and apparatus for monitoring processes in living cells |
| ES2372563T5 (es) | 2009-02-11 | 2022-06-14 | Braun Avitum Ag | Dispositivo para el tratamiento extracorporal de sangre |
| WO2011154514A1 (de) | 2010-06-11 | 2011-12-15 | B. Braun Avitum Ag | Vorrichtung zur extrakorporalen blutbehandlung mit einer messeinrichtung zur bestimmung der lumineszenz der verbrauchten dialysierflüssigkeit |
-
2012
- 2012-06-15 EP EP12172251.6A patent/EP2674103A1/en not_active Withdrawn
-
2013
- 2013-06-14 JP JP2015516629A patent/JP6242883B2/ja active Active
- 2013-06-14 IN IN165DEN2015 patent/IN2015DN00165A/en unknown
- 2013-06-14 AU AU2013276453A patent/AU2013276453B2/en not_active Ceased
- 2013-06-14 CA CA2876542A patent/CA2876542C/en active Active
- 2013-06-14 KR KR1020157001132A patent/KR102058260B1/ko not_active Expired - Fee Related
- 2013-06-14 WO PCT/EP2013/062366 patent/WO2013186357A1/en not_active Ceased
- 2013-06-14 US US13/917,944 patent/US10010289B2/en active Active
- 2013-06-14 EP EP13728759.5A patent/EP2861127B1/en active Active
- 2013-06-14 EA EA201492106A patent/EA028556B1/ru not_active IP Right Cessation
- 2013-06-14 BR BR112014031407-1A patent/BR112014031407B1/pt active IP Right Grant
- 2013-06-14 CN CN201380031614.XA patent/CN104363820B/zh active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN104363820B (zh) | 2019-07-05 |
| EP2674103A1 (en) | 2013-12-18 |
| JP2015521492A (ja) | 2015-07-30 |
| CA2876542A1 (en) | 2013-12-19 |
| CA2876542C (en) | 2020-08-18 |
| IN2015DN00165A (enExample) | 2015-06-12 |
| WO2013186357A1 (en) | 2013-12-19 |
| BR112014031407A2 (pt) | 2017-06-27 |
| EP2861127A1 (en) | 2015-04-22 |
| CN104363820A (zh) | 2015-02-18 |
| KR20150024405A (ko) | 2015-03-06 |
| AU2013276453A1 (en) | 2015-01-22 |
| EA028556B1 (ru) | 2017-11-30 |
| AU2013276453B2 (en) | 2017-08-17 |
| EA201492106A1 (ru) | 2015-05-29 |
| JP6242883B2 (ja) | 2017-12-06 |
| KR102058260B1 (ko) | 2019-12-20 |
| US10010289B2 (en) | 2018-07-03 |
| EP2861127B1 (en) | 2020-09-09 |
| US20140046150A1 (en) | 2014-02-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112014031407B1 (pt) | Método e dispositivo para o monitoramento de um tratamento de sangue extracorpóreo de um paciente e aparelho de tratamento de sangue extracorpóreo para execução de um tratamento de sangue extracorpóreo em um paciente | |
| CN103533972B (zh) | 用于监测患者的治疗优选地用于监测血液透析、血液透滤和/或腹膜透析的方法和设备 | |
| Vonach et al. | Application of mid-infrared transmission spectrometry to the direct determination of glucose in whole blood | |
| Tatarkovič et al. | The minimizing of fluorescence background in Raman optical activity and Raman spectra of human blood plasma | |
| EP2577270A1 (en) | Method and device for measuring and monitoring concentration of substances in a biological fluid | |
| KR20130038347A (ko) | 생물학적 유체 내 중간 및 단백질 결합 요독의 함량 측정 방법 및 장치 | |
| Uhlin et al. | Optical monitoring of dialysis dose | |
| Zain et al. | Photon counting polarimetry measurement towards non-invasive biomedical glucose monitoring | |
| Holmar et al. | Quantification of indoxyl sulphate in the spent dialysate using fluorescence spectra | |
| Holmar et al. | Beta2-microglobulin measurements in the spent dialysate using fluorescence spectra | |
| CN107941719B (zh) | 一种溶液表面反射吸光度测定装置及其应用 | |
| Nguyen Le et al. | An Automatic Control System for Measuring Stokes Polarization and Utilizing UV Light Source | |
| CN120052822A (zh) | 一种血液内水分浓度的检测方法和检测系统 | |
| CN107677622A (zh) | 一种溶液表面反射吸光度测定装置 | |
| Heine et al. | Determination of the optical properties of anisotropic turbid media using an integrating sphere | |
| Sanders et al. | Department of Physics University of California, Santa Barbara Santa Barbara, CA 93106 | |
| WO2007073227A1 (fr) | Procede et dispositif diagnostiques et procede de preparation de serum |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 14/06/2013, OBSERVADAS AS CONDICOES LEGAIS. |